V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010284 | 310011156 | 1.98 | 78.5 | Curative (C) | 2016-04-08 | 2016-09-17 | Bevacizumab 7.5mg/kg | 02 | N | 310007053 | BEVACIZUMAB |
| 310010285 | 310007475 | null | 69 | Not known (9) | 2015-06-17 | 2015-06-19 | SMILE | Y | N | 310007063 | TRIAL |
| 310010286 | 310007479 | 1.8 | null | Neo-adjuvant (N) | 2014-11-02 | 2014-12-12 | CHOP - 21 days | N | N | 310007089 | CHOP |
| 310010287 | 310003669 | 1.65 | 73 | Adjuvant (A) | 2019-09-27 | 2019-09-27 | CHOP | 02 | null | 310007095 | CHOP |
| 310010288 | 310007482 | 1.82 | 88 | Palliative (P) | 2019-04-20 | 2019-04-26 | Bevacizumab | 1 | N | 310007096 | BEVACIZUMAB |
| 310010289 | 310003678 | null | 77.8 | Palliative (P) | null | 2015-05-09 | CHOP - 21 days | N | N | 310007130 | CHOP |
| 310010290 | 310010555 | 1.86 | 64.9 | Palliative (P) | 2014-11-12 | 2014-12-03 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310007131 | LIPOSOMAL DOXORUBICIN |
| 310010291 | 310011814 | 1.94 | null | Palliative (P) | 2015-03-20 | 2015-03-27 | CHOP - 21 days | 02 | N | 310007139 | CHOP |
| 310010292 | 310003684 | 1.58 | 74.7 | Palliative (P) | 2014-04-17 | 2014-05-02 | Liposomal Doxorubicin 40mg/m2 | 2 | N | 310007164 | LIPOSOMAL DOXORUBICIN |
| 310010293 | 310010557 | 1.59 | 47.7 | Adjuvant (A) | 2017-10-11 | 2017-10-15 | Trial Unspecified | 02 | N | 310007171 | TRIAL |
| 310010294 | 310003691 | 1.74 | null | Palliative (P) | 2018-03-02 | 2018-03-04 | CHOP - 21 days | N | N | 310007204 | CHOP |
| 310010295 | 310007494 | 1.7 | 94 | Palliative (P) | 2014-04-08 | 2014-04-09 | GemCarbo Days 1+8 | 02 | N | 310007213 | GEMCARBO |
| 310010296 | 310009494 | 1.71 | 75.8 | null | 2016-12-13 | 2016-12-20 | CHOP - 21 days | 2 | N | 310007215 | CHOP |
| 310010297 | 310003694 | 1.75 | 77.8 | Palliative (P) | 2016-10-25 | 2016-10-26 | Bevacizumab 7.5mg/kg | 99 | N | 310007216 | BEVACIZUMAB |
| 310010298 | 310010561 | 1.56 | 70.9 | Palliative (P) | 2018-11-17 | 2018-11-17 | Trial Unspecified | N | N | 310007266 | TRIAL |
| 310010299 | 310007500 | null | null | null | 2013-10-03 | 2013-11-10 | CHOP | 2 | N | 310007284 | CHOP |
| 310010300 | 310007500 | 1.72 | 65 | null | 2016-03-03 | 2016-03-11 | Liposomal Doxorubicin 50mg/m2 | 02 | N | 310007284 | LIPOSOMAL DOXORUBICIN |
| 310010301 | 310003706 | 1.71 | 84.5 | Palliative (P) | 2018-11-10 | 2018-11-10 | GemCarbo Days 1+8 | N | N | 310007302 | GEMCARBO |
| 310010302 | 310007503 | null | 84.55 | Palliative (P) | 2018-01-14 | 2018-01-18 | GEMCARBO | 2 | N | 310007311 | GEMCARBO |
| 310010303 | 310003711 | 1.61 | 82 | Adjuvant (A) | 2015-09-25 | 2015-11-05 | Bevacizumab 15mg/kg | N | N | 310007315 | BEVACIZUMAB |
| 310010304 | 310003715 | 1.65 | 78.5 | Palliative (P) | null | 2017-12-17 | Liposomal Doxorubicin (Caelyx) | 2 | N | 310007322 | LIPOSOMAL DOXORUBICIN |
| 310010305 | 310003718 | 1.47 | null | Curative (C) | 2017-01-19 | 2017-01-21 | CHOP | 02 | null | 310007357 | CHOP |
| 310010306 | 310007509 | 1.52 | 75 | Palliative (P) | 2016-04-09 | 2016-04-09 | Liposomal Doxorubicin (20mg/m2) | N | N | 310007362 | LIPOSOMAL DOXORUBICIN |
| 310010307 | 310007509 | 1.72 | 71.6 | Disease modification (D) | 2017-12-10 | 2017-12-15 | CHOP - 14 days | 2 | N | 310007362 | CHOP |
| 310010308 | 310003722 | 1.59 | 62.3 | Adjuvant (A) | 2015-11-24 | 2015-12-22 | Trial Unspecified | Y | N | 310007366 | TRIAL |
| 310010309 | 310003724 | 1.89 | 99.2 | Palliative (P) | 2017-11-28 | 2017-12-03 | GemCarbo Days 1+8 | N | N | 310007370 | GEMCARBO |
| 310010311 | 310003731 | 1.95 | 82.8 | Palliative (P) | 2016-08-19 | 2016-08-24 | Bevacizumab 7.5mg/kg | N | N | 310007389 | BEVACIZUMAB |
| 310010312 | 310003732 | 1.68 | 70.8 | Curative (C) | 2017-11-30 | 2017-11-30 | Trial Unspecified | Y | N | 310007391 | TRIAL |
| 310010313 | 310010567 | 1.73 | 85.8 | Curative (C) | 2013-10-11 | 2013-10-11 | Trial Unspecified | 2 | N | 310007408 | TRIAL |
| 310010314 | 310003735 | 1.68 | 45 | Curative (C) | 2015-03-24 | 2015-06-30 | CHOP - 21 days | 02 | N | 310007411 | CHOP |
| 310010316 | 310003742 | 1.74 | 111 | Palliative (P) | 2013-04-17 | 2013-04-20 | Bevacizumab 7.5mg/kg | N | N | 310007443 | BEVACIZUMAB |
| 310010317 | 310011168 | 1.72 | 74 | Not known (9) | 2015-10-02 | 2016-03-02 | CHOP | N | N | 310007451 | CHOP |
| 310010319 | 310003749 | null | 78.3 | Palliative (P) | 2014-10-05 | 2014-10-08 | GemCarbo Days 1+8 | N | N | 310007466 | GEMCARBO |
| 310010320 | 310007529 | 1.74 | 74.9 | null | null | 2017-02-09 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007468 | LIPOSOMAL DOXORUBICIN |
| 310010321 | 310003756 | 1.67 | 90 | Not known (9) | 2015-09-02 | 2015-09-03 | Trial Unspecified | 01 | N | 310007478 | TRIAL |
| 310010322 | 310003757 | 1.6 | 75.2 | Adjuvant (A) | null | 2014-02-11 | Bevacizumab | N | N | 310007481 | BEVACIZUMAB |
| 310010324 | 310003766 | 1.52 | 82.2 | null | 2016-06-19 | 2016-06-21 | GEMCARBO | null | N | 310007512 | GEMCARBO |
| 310010325 | 310003769 | 1.63 | null | Palliative (P) | null | 2014-08-20 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007518 | LIPOSOMAL DOXORUBICIN |
| 310010326 | 310003772 | 1.56 | 59.4 | Disease modification (D) | 2014-07-01 | 2014-07-01 | Trial Unspecified | 01 | N | 310007520 | TRIAL |
| 310010327 | 310003774 | 1.59 | 62.45 | Palliative (P) | null | 2014-01-30 | CHOP | 02 | N | 310007527 | CHOP |
| 310010328 | 310003776 | null | 66.15 | Palliative (P) | 2014-08-10 | 2015-03-25 | CARBOPLATIN + GEMCITABINE | 02 | N | 310007538 | GEMCARBO |
| 310010329 | 310003781 | 1.81 | 116.4 | null | 2018-06-03 | 2018-06-14 | Bevacizumab 15mg/kg | N | N | 310007548 | BEVACIZUMAB |
| 310010330 | 310003783 | 1.68 | 144.4 | Palliative (P) | 2013-10-03 | 2013-11-07 | Bevacizumab 7.5mg/kg | N | N | 310007554 | BEVACIZUMAB |
| 310010331 | 310007547 | 1.8 | null | Palliative (P) | 2015-04-06 | 2015-04-06 | Bevacizumab 7.5mg/kg | N | N | 310007569 | BEVACIZUMAB |
| 310010332 | 310003794 | 1.63 | 65.7 | Adjuvant (A) | 2018-03-30 | 2018-04-02 | CHOP | N | null | 310007578 | CHOP |
| 310010333 | 310003797 | 1.82 | 66.4 | Palliative (P) | 2019-01-13 | 2019-02-03 | Liposomal Doxorubicin (Caelyx) | N | null | 310007587 | LIPOSOMAL DOXORUBICIN |
| 310010334 | 310009526 | 1.76 | 78 | Disease modification (D) | 2016-03-07 | 2017-06-08 | Bevacizumab | 1 | N | 310007593 | BEVACIZUMAB |
| 310010335 | 310007555 | 1.68 | 81.5 | Not known (9) | 2016-05-13 | 2016-06-04 | Bevacizumab 7.5mg/kg | N | N | 310007610 | BEVACIZUMAB |
| 310010336 | 310003803 | 1.68 | 116.6 | Curative (C) | 2017-07-15 | 2017-07-15 | CHOP - 14 days | 02 | Y | 310007613 | CHOP |
| 310010337 | 310003807 | null | 71.7 | Disease modification (D) | 2015-08-05 | 2015-08-07 | Liposomal Doxorubicin 40mg/m2 | N | N | 310007646 | LIPOSOMAL DOXORUBICIN |